Thousands of new cancer cases in Ontario each year due to environmental exposures

August 08, 2016

TORONTO, ON (Aug. 8, 2016) - Between 3,540 and 6,510 new cancer cases in Ontario each year result from environmental factors, says a new report from Cancer Care Ontario and Public Health Ontario (PHO).

The report, Environmental Burden of Cancer in Ontario, estimates how many new cancer cases occur each year in the province as a result of exposure to cancer-causing agents, or carcinogens, that exist in our environment. The estimated burden of cancer from environmental carcinogens is significant, particularly when compared to other known cancer risk factors. The report found that environmental carcinogens represent roughly twice the cancer burden from drinking alcohol and about one-half the cancer burden from smoking.

"This report focuses on cancer-causing agents that Ontarians are exposed to every day simply by breathing, eating, drinking and being in the sun," says Dr. Ray Copes, chief of environmental and occupational health, PHO. "Interestingly, three main carcinogens stand out as being particularly important - ultraviolet (UV) radiation from the sun, radon gas, and fine particle (PM2.5) air pollution."

The report ranks 23 environmental carcinogens according to the estimated annual number of new cancer cases in Ontario that each carcinogen would be associated with at current exposure levels. Key findings include: "Understanding the factors that affect our cancer risk is an important step on the path to a healthier future. By focusing prevention efforts on the carcinogens associated with the highest number of new cancer cases, we can significantly reduce the environmental cancer burden in Ontario," says Alice Peter, director, population health & prevention, Cancer Care Ontario. "With this report, we can effect change through awareness of these environmental carcinogens; this will require the coordinated efforts and expertise from all levels of government, scientists, industry experts, non-governmental organizations and Ontarians."

Environmental Burden of Cancer in Ontario is the fifth report in Cancer Care Ontario's Cancer Risk Factors in Ontario series, and the first produced jointly by Cancer Care Ontario and PHO in the series.
About Cancer Care Ontario:

Cancer Care Ontario plays an important role in equipping health professionals, organizations and policy-makers with the most up-to-date cancer knowledge and tools to prevent cancer and deliver high quality patient care.

It does this by collecting and analyzing data about cancer services and combining it with evidence and research that is shared with the healthcare community in the form of guidelines and standards. It also monitors and measures the performance of the cancer system, and oversees a funding and governance model that ties funding to performance, making healthcare providers more accountable and ensuring value for investments in the system.

Cancer Care Ontario actively engages people with cancer and their families in the design, delivery and evaluation of Ontario's cancer system, and works to improve the performance of Ontario's cancer system by driving quality, accountability, innovation and value.

About Public Health Ontario:

Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and reducing inequities in health. Public Health Ontario links public health practitioners, front-line health workers and researchers to the best scientific intelligence and knowledge from around the world. For the latest PHO news, follow us on Twitter: @publichealthON.

For more information, please contact:

Janet Wong
Public Health Ontario

Jayani Perera
Cancer Care Ontario

Public Health Ontario

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to